REGISTRATION LINK :
Pr Hervé Watier : Hervé Watier is Professor of Immunology at the Faculty of Medicine, Tours, France, and Head of the Laboratory of Immunology in the University Hospital of Tours. He started his medical studies in Lille and his scientific training at the Pasteur Institute of Lille in 1989-91 before completing his MD and PhD theses in Tours. Through pharmacogenetic approaches, he discovered the importance of FcγRIIIA-dependent mechanisms in the action of cytolytic monoclonal antibodies in humans in 2002 and he then specialised in the structure-function relationship studies of therapeutic antibodies. He is coordinating the laboratory of excellence (LabEx) “MAbImprove” since 2011 and a regional program dedicated to biopharmaceuticals since 2013.
Dr Thierry WURCH, Sr.Director – Global External Innovation – Ipsen Since March 20, Thierry is External Innovation lead in Oncology at IPSEN. Dr. Wurch completed a Ph.D. in Molecular and Cellular Biology at the University Louis Pasteur (Strasbourg, FR), followed by post-doctoral training at the University of Ghent (BE). Back to France in 1994, he raised a molecular biology laboratory at the Pierre FABRE Research Center in Castres (FR). In 2003, he moved to the Center for Immunology Pierre FABRE where he established a Molecular and Cellular Biology Department dedicated to molecular pharmacology and protein and antibody engineering. In 2011, Thierry went to SERVIER where he successively led the immunotherapy discovery research programs until end 2016 then joined the newly created External Research and Innovation group overseeing global scouting activities in Oncology. Thierry Wurch is member of the Editorial board of MABS Journal (Taylor & Francis), Distinguished Advisor of The Antibody Society, member of the Scientific advisory board of MabDesign and Chair of the IUPHAR-NC Antibody Committee. He is co-author of more than 90 publications.
(Wednesday) 17 h 00 min - 18 h 30 min ECT
AFPT - Le Club Phase 1